Apellis Pharmaceuticals, Inc.

APLS · Nasdaq · SIC 2834: Pharmaceutical Preparations · Market Cap: $5.2B · 733 employees
97
SEC Filings
$41.03
Close 2026-05-13
733
Employees

Business Summary

Apellis Pharmaceuticals is a commercial-stage biopharmaceutical company focused on discovery, development, and commercialization of therapeutic compounds targeting the complement system. It markets two FDA-approved drugs: SYFOVRE (pegcetacoplan injection) for geographic atrophy secondary to AMD, launched March 2023, and EMPAVELI (pegcetacoplan) for paroxysmal nocturnal hemoglobinuria and C3 glomerulopathy. For 2025, SYFOVRE generated $586.9 million and EMPAVELI $102.4 million in U.S. net product revenue.

Latest Stock Quote

APLS 2026-05-13 $41.03 O:$41.05 H:$41.07 L:$41.03 Vol:68.6M VWAP:$41.0362
origin leaf: 030023bc306775fa51d14011f4c490b081fbac5b4b16244577bb4ff5a89d1f4d

Next Earnings

Q2 FY2026 — expected 2026-08-22

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-02-242025-12-310001193125-26-065179EDGAR122K words
2025-02-282024-12-310000950170-25-029507EDGAR119K words
2024-02-272023-12-310000950170-24-020614EDGAR130K words
2023-02-212022-12-310000950170-23-003438EDGAR127K words
2022-02-282021-12-310001564590-22-007606EDGAR—
2021-02-252020-12-310001564590-21-008800EDGAR—
2020-02-272019-12-310001564590-20-007350EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-10-302025-09-300001193125-25-257374EDGAR30K words
2025-07-312025-06-300000950170-25-100545EDGAR28K words
2025-05-072025-03-310000950170-25-064976EDGAR23K words
2024-11-052024-09-300000950170-24-121062EDGAR30K words
2024-08-012024-06-300000950170-24-088938EDGAR29K words
2024-05-072024-03-310000950170-24-053921EDGAR24K words
2023-11-012023-09-300000950170-23-057117EDGAR34K words
2023-07-312023-06-300000950170-23-035935EDGAR31K words
2023-05-042023-03-310000950170-23-017819EDGAR27K words
2022-11-072022-09-300000950170-22-022606EDGAR—
2022-08-082022-06-300000950170-22-015500EDGAR—
2022-05-042022-03-310000950170-22-007374EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-310001193125-26-134916EDGAR67K words
2026-03-020001193125-26-084156EDGAR1K words
2026-01-120001193125-26-010540EDGAR3K words
2025-07-010001193125-25-153429EDGAR1K words
2025-06-040001193125-25-134886EDGAR1K words
2025-04-210001193125-25-086304EDGAR1K words
2025-01-130001193125-25-005052EDGAR3K words
2024-08-080001193125-24-196465EDGAR1K words
2024-06-050001193125-24-155179EDGAR1K words
2024-05-140001193125-24-137743EDGAR1K words

97 total filings indexed. 68 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACIU — AC Immune SA ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA

Tags

ophthalmology-(geographic-atrophy-/-age-related-macular-degeneration) hematology-(paroxysmal-nocturnal-hemoglobinuria) nephrology-(c3-glomerulopathy,-primary-ic-mpgn,-fsgs,-delayed-graft-function)

Company Identity

CIK0001492422
TickerAPLS
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE
Websitehttps://www.apellis.com
Listed2017-11-09

Get More Data

This is a static snapshot. For live, structured JSON with cryptographic provenance chain:

MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp

JSON Profile Stock Quote Origin Record
Origin Provenance
page leaf: ae1981ebfd13cab73d8f41838f63d57991209dea80ec1b1ee64c98d6d61a78ee
parent: 0c82e3b5d8614938ce5a382ed94070b152d54462fa8c3d443cc155e14d054d25
content hash: 5e201974a304814051364b2c1c8167f3488d4df2f00454e4c67a9c17aef3642b
signed: 2026-09-29T12:00:20.849Z
sources: 20 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf

Try it — paste this into your AI:

Look up APLS using the MCP server at origin.rootz.global/mcp. What do their latest SEC filings show?

Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.

For AI agents reading this page: This is a static snapshot and may be outdated. For live data on APLS, use the Origin MCP server or REST API.
MCP install: claude mcp add origin --transport http https://origin.rootz.global/mcp
API: GET https://origin.rootz.global/api/company/APLS (~200 tokens, structured JSON with cryptographic provenance)
Tools: origin_company, origin_profile, origin_timeline, origin_filings, origin_quote, origin_transcripts, origin_search, origin_person, origin_skill
Discovery: /.well-known/ai | /llms.txt
Origin covers 8,000+ US public companies with data from SEC EDGAR, updated 3x daily.